Pediatric cancer recurrence remains one of the most pressing challenges in the medical field, particularly for families affected by conditions like gliomas.Recent advancements in AI could significantly change the landscape of cancer risk prediction, allowing for more accurate assessments of brain tumor recurrence among young patients.